InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today ...

Shares of InMode Ltd INMD are trading lower Monday morning after the Israeli medical technology company said a special ...

InMode is in the news given a rumored take-private deal. Read more on what investors need to know about recent developments.

InMode halts control sale after rejecting final bids including Centroid Sale process shelved as InMode board rejects all final bids, including from Centroid ...

InMode Ltd. is rated a Strong Buy due to its robust balance sheet, proprietary technology, and international growth. Learn more about INMD stock here.

Interested investors are welcome to contact their BTIG salesperson and schedule a meeting. For more information about the event, visit InMode's investor relations site here.

Despite the quarterly beat, InMode’s stock declined after the company issued full-year 2026 guidance below Wall Street expectations. The company forecasts adjusted earnings of $1.43 to $1.48 per share ...

InMode Ltd. (NASDAQ:INMD) Q4 2025 Earnings Call Transcript February 10, 2026 InMode Ltd. beats earnings expectations.

InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues.

There's an interesting catalyst in the making that might drive even more sales. Buying more shares of one of your winning investments can feel good. Aside from confirming your commitment to a smart ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

Let's talk about what we know about cosmetic surgery. First, it's costly. It's invasive, leaves scars, and has long recovery times. Cosmetic surgery is mostly for the rich and famous -- not regular ...